The Orthopedic Cartilage Repair ecosystem spans upstream suppliers of biomaterials and device components, midstream manufacturers and system integrators that assemble and validate clinical solutions, and downstream distribution channels that deliver finished products to hospitals, orthopedic clinics, and research institutions. Value is created when raw polymers, collagen matrices, and growth‑factor kits are combined into implantable devices, then captured through licensing, reimbursement, and procedure fees. Regulatory approval and clinical evidence act as gatekeepers that shape the flow of technology from R&D labs to surgical suites. The ecosystem therefore links material science, device engineering, commercialization, and patient care within a tightly regulated value chain.